SCHEMBL23928845

SCHEMBL23928845

CC(C)(C)OC(=O)N1CC2(CC(=O)c3ccc(F)cc3O2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 3/20 0.51
HDAC1 Q13547 5/20 0.42
HDAC2 Q92769 5/20 0.42
HDAC3 O15379 4/20 0.42
HDAC4 P56524 4/20 0.42
HDAC7 Q8WUI4 4/20 0.42
HDAC10 Q969S8 4/20 0.42
HDAC11 Q96DB2 4/20 0.42
HDAC8 Q9BY41 4/20 0.42
HDAC6 Q9UBN7 4/20 0.42
HDAC9 Q9UKV0 4/20 0.42
HDAC5 Q9UQL6 4/20 0.42
HSD11B1 P28845 1/20 0.41
BUB1 O43683 1/20 0.41
GPR183 P32249 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP19A1 P11511 1/20 0.39
ALDH1A1 P00352 1/20 0.38
MAOB P27338 1/20 0.38
RORC P51449 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30094665 0.91 HSD11B1 (0.51) CHRNA7HDAC1HDAC2HDAC3HDAC4
SCHEMBL538735 0.90 KMT2A (0.50) CHRNA7HDAC1HDAC2HDAC3HDAC4
SCHEMBL3589220 0.88 HDAC3 (0.41) CHRNA7HDAC1HDAC2HDAC3HDAC4
SCHEMBL30016576 0.87 HDAC3 (0.44) CHRNA7HDAC1HDAC2HDAC3HDAC4
SCHEMBL19030641 0.85 ESR2 (0.39) CHRNA7HDAC1HDAC2GPR183RORC
SCHEMBL30953804 0.85 ALDH1A1 (0.43) CHRNA7HDAC1HDAC2HDAC3HDAC4
SCHEMBL23928877 0.84 ATM (0.51) CHRNA7HDAC1HDAC2HDAC3HDAC4
SCHEMBL31236021 0.83 HDAC3 (0.43) CHRNA7HDAC1HDAC2HDAC3HDAC4
SCHEMBL23928878 0.82 CHRNA7 (0.54) CHRNA7HDAC1HDAC2HDAC3HDAC4
SCHEMBL1690779 0.81 HSD11B1 (0.60) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112823157-B Spirochroman derivatives 吉瑞工厂 2024-08-09 CN disclosed
EP-3820869-B1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT (HU) 2023-08-30 EP disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 CHRNA7 1/4885HDAC1 313/4885HDAC2 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.